Metabolic syndrome and atherosclerotic cardiovascular disease risk assessment among adult patients with Thyroid diseases in Chemchemal chronic disease control center-Sulaimania
DOI:
https://doi.org/10.56056/amj.2022.132Keywords:
Metabolic syndrome, Thyroid disease, Atherosclerotic cardiovascular disease riskAbstract
Background and objectives: Metabolic syndrome is risk factor for atherosclerotic cardiovascular disease. The study’s objective was to find the prevalence of metabolic syndrome among adult patients with thyroid diseases in Chemchemal chronic disease control center-Sulaimani, and to assess their atherosclerotic cardiovascular disease risk.
Methods: A cross-sectional analytical study conducted on 141 patients that attended the center; from 1st July 2018 to 1st January 2019. A structured questionnaire was administered and data was collected on socio-demographic, medical and behavioral history. Anthropometric measures and blood pressure were taken. Fasting venous blood samples were analyzed to measure lipids, glucose and thyroid hormones. The American Heart Association / National Heart, Lung, and Blood Institute criteria, was used for the definition of metabolic syndrome. Pooled Cohort Equation from the American College of Cardiology/ American Heart Association was used for atherosclerotic cardiovascular disease risk assessment of each patient.
Results: The prevalence of metabolic syndrome among thyroid patients was 80%, 78.7 % of females and 77.4% of males had metabolic syndrome. Hypothyroidism, central obesity and hypertension were significantly higher among females. Hypothyroidism was the major thyroid disease, found in 69.5% of the patients and thyrotoxicosis found in 30.5% of them. Atherosclerotic cardiovascular disease risk was high in majority of thyroid patients.
Conclusions: The prevalence of metabolic syndrome and atherosclerotic cardiovascular disease risk were significantly higher among thyroid patients than normal population.
Downloads
References
Eckel RH. The metabolic syndrome. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's editors, principles of internal medicine. 19th ed. New York: McGraw Hill; 2015. 2449-52.
Strachan MWJ, Newell-Price JDC, Thyroid gland, Endocrinology, In: Ralston SH, Penman ID, Strachan MWJ. Davidson editors, Principle and practice of medicine, 23rded. 2018, China, Elsevier Ltd, 634.
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80.
American College of Physicians. Endocrinology and Metabolism. MKSAP: Medical Knowledge Self-Assessment Program 17. Philadelphia, PA: American College of Physicians. 2015; pp. 3-4.
Kambel P, Deshmukh PR, Garge N. Metabolic syndrome in adult population of rural Wardha, central Indian. J Med Res.2010; 132, 701-5.
IC Health. National Cardiovascular Disease Database. Sticker No: SE/04/233208. Supported by Ministry of Health & Family Welfare, Government of India and World Health Organization. Available from:
http://www.searo.who.int/india/topics/cardiovascular_diseases/NCD_Resources_National_CVD_ database-Final_Report.pdf.ua=1. [Last accessed on 2019 Jul 25].
Indian Council of Medical Research (ICMR) - India Diabetes (INDIAB) Study-Phase I, Final report (2008-2011), New Delhi. Available from: https://www.icmr.nic.in/sites/default/files/reports/Executive_summary_INDIAB_Phase_I.pdf.
Dalvand S, Niksima Sh, MeshKani R, et al. Prevalence of Metabolic Syndrome among Iranian Population: A Systematic Review and Meta-analysis. Iran J Public Health. 2017; 46(4): 456–67.
Ismael SA, Ahmed HF, Hasan MT. Prevalence of metabolic syndrome in a sample of population in Erbil city, Iraq. Zanco J. Med. Sci. 2016; 20(2): 1280-87.
Kota SK, Meher LK, Krishna S, Modi KD. Hypothyroidism in metabolic syndrome. Indian J Endocrinol Metab. 2012; 16(2):332-33.
Agarwal G, Sudhakar MK, Singh M, Senthil N, Rajendran A. The prevalence of thyroid dysfunction among South Indian women with metabolic syndrome. J Clin Diag Res. 2011: 5:213-16.
Khatiwada S, Sah SK, Rajendra KC, Baral N, Lamsal M. Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome. Clin Diabetes and Endocrinol. 2016; 2 (3):1-5.
Haque R, Ferdousi S, Ferdousi SS, Rahman W, Uddin MN, Hoque MM. Metabolic Syndrome in Hypothyroid Patients. Bangladesh J Med Biochem. 2014;7 (2): 57-61.
Roos A, Bakker SJL, Links TP, Gans ROB, Wolffenbuttel BHR. Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects. J Clin Endocrinol Metab. 2007;92(2):491-6.
Meher LK, Raveendranathan SK, Kota SK, Sarangi J, Jali SN. Prevalence of hypothyroidism in patients with metabolic syndrome. Thyroid Res Practice.2013;10(2):60-4.
Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med. 2000;132:270-8.
Hamlaouia ML, Ayachia A, Dekakenb A, Gouric A. Relationship of metabolic syndrome and its components with thyroid dysfunction in Algerian patients. Diabetes Metab Syndr. 2018;12(1):1-4.
Ogbera AO, Kuku S, Dada O. The metabolic syndrome in thyroid disease: A report from Nigeria. Indian J Endocrinol Metab. 2012;16(3), 417-22.
Yu RML, Ho Tan G. Prevalence of Metabolic Syndrome among Adult Filipino Patients with Thyroid Disease in an Outpatient Clinic in Cebu City, Philippines from 2004–2015. J Diabetes Res Endocrinol. 2017; 1(2), 1-7.
Ogbera AO, Fasanmade O, Isiba A. The scope of cardiac complications of thyrotoxicosis in Lagos Nigeria. Pak J Med Sci.2007;23(5):671-5.
Biondi, B. & Klein, I. Hypothyroidism as a risk factor for cardiovascular disease. Endocr. 2004:24:1.
Fletcher AK & Weetman AP. Hypertension and hypothyroidism. J Hum Hypertens. 1998,12:79-82.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Imdad Ahmed Mohammed, Bushra Mohammed Ali
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
